Nordhealth AS

Nordhealth AS

NORDH · OL · Healthcare / Health Information Services

26.20NOK-0.40 (-1.50%)

Price History

Full chart

Market Stats

Previous Close26.60
Open26.20
Day Range26.20 – 26.20
52-Week Range21.20 – 38.40
Volume5
Market Cap2.08B
P/E (TTM)0.00
Forward P/E0.00
EPS-2.20
Dividend Yield0.00%
Beta0.33
50-Day Avg24.22
200-Day Avg27.56

About

Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally. Its products include Provet, a practice management software platform for veterinary clinics and enterprise groups, providing appointment scheduling, patient management, electronic health records, billing and invoicing, reporting and analytics, government compliance tools, communication features, inventory management, and workflow automation; Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychiatrists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company's products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to the implementation of SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. Nordhealth AS was founded in 2001 and is based in Oslo, Norway.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Charles MacBain
  • Employees447
  • HeadquartersHasleveien 28A, Oslo, Norway, 0571, Norway
  • Websitehttps://nordhealth.com

Leadership

  • Mr. Charles MacBainGroup Chief Executive Officer
  • Alexander CramGroup Chief Financial Officer
  • Dr. James StanierChief Technology Officer
  • Mr. Janne Heikki HuttunenChief Innovation Officer of Veterinary & Board Member
  • Mr. Karan WalliaCEO of the Therapy Business Unit

Financials

Income Statement

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--12.68M20.30M31.05M36.83M45.67M50.84M
Growth (%)---+60.04%+52.96%+18.60%+24.03%+11.31%
Cost of Revenue--1.75M3.56M4.78M5.17M6.65M9.54M
Gross Profit--10.93M16.74M26.27M31.65M39.03M41.30M
Gross Margin--86.20%82.45%84.61%85.96%85.44%81.23%
Operating Expense--8.96M21.20M40.95M43.04M46.75M53.76M
Operating Income--1.97M-4.46M-14.68M-11.39M-7.73M-12.47M
Operating Margin--15.56%-21.96%-47.27%-30.92%-16.92%-24.52%
EBITDA--3.55M-369.00K-5.41M-659.00K4.21M-965.00K
EBITDA Margin--28.02%-1.82%-17.42%-1.79%9.23%-1.90%
Net Income--1.93M-4.73M-14.26M-11.13M-7.67M-12.68M
Net Income Margin--15.20%-23.31%-45.94%-30.23%-16.80%-24.94%
Interest Expense--40.00K41.00K17.00K8.00K37.00K44.00K
Interest Expense % of Total Revenue--0.32%0.20%0.05%0.02%0.08%0.09%

Balance Sheet

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--12.90M125.13M114.89M91.94M82.96M71.53M
Total Liabilities--7.94M10.62M16.27M9.17M9.33M9.97M
Total Equity--4.95M114.51M98.63M82.77M73.63M61.56M
Cash--3.77M26.21M15.51M5.05M4.09M4.36M

Cash Flow

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.57M5.57M5.57M5.57M-6.53M-5.22M1.85M719.00K
Investing Cash Flow-92.14M-92.14M-92.14M-92.14M-2.09M-2.63M-2.77M-
Financing Cash Flow109.02M109.02M109.02M109.02M-2.08M-2.35M0-
Capital Expenditure3.38M3.38M3.38M3.38M6.80M5.72M5.02M5.09M
Free Cash Flow--2.94M2.19M-13.33M-10.95M-3.17M-4.37M
Dividends Paid3.73M3.73M3.73M3.73M0---
FCF to OCF--52.81%39.34%204.25%209.57%-171.65%-608.34%
Dividend Paid to FCF--126.90%170.37%0.00%---

Earnings

Report DateSep 30, 2021Nov 30, 2021Mar 8, 2022Mar 7, 2023May 16, 2023Aug 22, 2023Nov 14, 2023Mar 5, 2024May 30, 2024Aug 20, 2024Nov 12, 2024Mar 4, 2025May 13, 2025Aug 19, 2025Nov 11, 2025Mar 4, 2026May 12, 2026Aug 18, 2026Nov 10, 2026
EPS Estimate0.000.000.000.00-----------0.00---
EPS Actual0.01-0.01-0.03-0.62-0.46-0.36-0.27-0.50-0.35-0.23-0.12-0.42-0.42-0.43-0.32-0.72-0.77-0.51-
Surprise-------------------
TimingPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.08B
Enterprise Value1.77B
Trailing P/E0.00
Forward P/E0.00
Price / Sales39.15
Price / Book3.20
EPS-2.20
Book Value7.52
Revenue (TTM)53.14M
Gross Profit (TTM)12.52M
EBITDA-10.51M
Profit Margin-29.94%
Operating Margin-25.64%
Return on Equity-25.83%
Return on Assets-12.63%
Shares Outstanding44.22M
Shares Float42.12M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%